ZA200110547B - Texture masked particles containing an active ingredient. - Google Patents
Texture masked particles containing an active ingredient.Info
- Publication number
- ZA200110547B ZA200110547B ZA200110547A ZA200110547A ZA200110547B ZA 200110547 B ZA200110547 B ZA 200110547B ZA 200110547 A ZA200110547 A ZA 200110547A ZA 200110547 A ZA200110547 A ZA 200110547A ZA 200110547 B ZA200110547 B ZA 200110547B
- Authority
- ZA
- South Africa
- Prior art keywords
- active ingredient
- particles containing
- masked particles
- texture masked
- texture
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title 1
- 239000002245 particle Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/745,243 US20020119196A1 (en) | 2000-12-21 | 2000-12-21 | Texture masked particles containing an active ingredient |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200110547B true ZA200110547B (en) | 2003-07-30 |
Family
ID=24995856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200110547A ZA200110547B (en) | 2000-12-21 | 2001-12-21 | Texture masked particles containing an active ingredient. |
Country Status (17)
Country | Link |
---|---|
US (2) | US20020119196A1 (ru) |
EP (1) | EP1219291B1 (ru) |
JP (1) | JP2002272817A (ru) |
KR (1) | KR20020050754A (ru) |
CN (1) | CN100544705C (ru) |
AR (1) | AR032037A1 (ru) |
AT (1) | ATE405250T1 (ru) |
AU (1) | AU783593B2 (ru) |
BR (1) | BR0106912A (ru) |
CA (1) | CA2365844C (ru) |
CO (1) | CO5390070A1 (ru) |
DE (1) | DE60135435D1 (ru) |
ES (1) | ES2311007T3 (ru) |
HK (2) | HK1045817B (ru) |
MX (1) | MXPA02000277A (ru) |
NZ (1) | NZ516341A (ru) |
ZA (1) | ZA200110547B (ru) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8900498B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for manufacturing a resulting multi-layer pharmaceutical film |
US20070281003A1 (en) | 2001-10-12 | 2007-12-06 | Fuisz Richard C | Polymer-Based Films and Drug Delivery Systems Made Therefrom |
US7357891B2 (en) | 2001-10-12 | 2008-04-15 | Monosol Rx, Llc | Process for making an ingestible film |
US11207805B2 (en) | 2001-10-12 | 2021-12-28 | Aquestive Therapeutics, Inc. | Process for manufacturing a resulting pharmaceutical film |
US8900497B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for making a film having a substantially uniform distribution of components |
US20110033542A1 (en) | 2009-08-07 | 2011-02-10 | Monosol Rx, Llc | Sublingual and buccal film compositions |
US10285910B2 (en) | 2001-10-12 | 2019-05-14 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
US20190328679A1 (en) | 2001-10-12 | 2019-10-31 | Aquestive Therapeutics, Inc. | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US8765167B2 (en) | 2001-10-12 | 2014-07-01 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US8603514B2 (en) | 2002-04-11 | 2013-12-10 | Monosol Rx, Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
US6723348B2 (en) * | 2001-11-16 | 2004-04-20 | Ethypharm | Orodispersible tablets containing fexofenadine |
GB2384986B (en) * | 2002-02-12 | 2004-01-07 | Reckitt Benckiser Healthcare | Compositions for the treatment of disorders of the upper gastrointestinal tract |
US20030190343A1 (en) * | 2002-03-05 | 2003-10-09 | Pfizer Inc. | Palatable pharmaceutical compositions for companion animals |
WO2003074029A1 (en) * | 2002-03-07 | 2003-09-12 | Vectura Limited | Fast melt multiparticulate formulations for oral delivery |
US20040001885A1 (en) * | 2002-06-27 | 2004-01-01 | Unchalee Kositprapa | Rapidly disintegrating antihistamine formulation |
US7384970B2 (en) * | 2003-03-24 | 2008-06-10 | Irm Llc | Inhibitors of cathepsin S |
US20050042289A1 (en) * | 2003-04-29 | 2005-02-24 | Yamanouchi Pharma Technologies, Inc. | Tablets and methods for modified release of hydrophylic and other active agents |
US20050053655A1 (en) * | 2003-09-05 | 2005-03-10 | Pharmaceutical Industry Technology And Development Center | Rapid disintegrating tablets (RDTs) for pharmaceutical use and method for preparing the same |
JPWO2005039542A1 (ja) * | 2003-10-27 | 2007-02-15 | アステラス製薬株式会社 | 口腔内崩壊錠用の薬物含有被覆微粒子 |
US20050175689A1 (en) * | 2003-10-27 | 2005-08-11 | Yamanouchi Pharmaceutical Co., Ltd. | Coated fine particles containing drug for intrabuccally fast disintegrating tablet |
US7201920B2 (en) | 2003-11-26 | 2007-04-10 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse of opioid containing dosage forms |
US7879354B2 (en) * | 2004-01-13 | 2011-02-01 | Mcneil-Ppc, Inc. | Rapidly disintegrating gelatinous coated tablets |
KR20070010132A (ko) * | 2004-03-25 | 2007-01-22 | 아스텔라스세이야쿠 가부시키가이샤 | 솔리페나신 또는 그의 염의 고형 제제용 조성물 |
CA2591761A1 (en) * | 2004-12-27 | 2006-07-06 | Astellas Pharma Inc. | Stable particulate pharmaceutical composition of solifenacin or salt thereof |
US20060198885A1 (en) * | 2005-02-22 | 2006-09-07 | Sun Pharmaceutical Industries Ltd. | Oral pharmaceutical composition |
EP1911444A1 (en) * | 2005-07-20 | 2008-04-16 | Astellas Pharma Inc. | Drug-containing coated fine particle for intrabuccally disintegrating preparation and method of producing the same |
US7815939B2 (en) * | 2005-07-20 | 2010-10-19 | Astellas Pharma Inc. | Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms |
US20070077300A1 (en) | 2005-09-30 | 2007-04-05 | Wynn David W | Oral compositions containing a salivation inducing agent |
WO2010060635A2 (en) * | 2008-11-28 | 2010-06-03 | Krka, D.D., Novo Mesto | Solid pharmaceutical composition comprising at least one stabilizing agent |
WO2010078542A1 (en) * | 2009-01-05 | 2010-07-08 | Mcneil-Ppc, Inc. | Three layer tablet containing cetirizine, pseudoephedrine, and naproxen |
CA2748728C (en) * | 2009-01-05 | 2017-01-03 | Mcneil-Ppc, Inc. | Tablet containing cetirizine, pseudoephedrine, and naproxen containing a barrier layer |
WO2010078541A1 (en) * | 2009-01-05 | 2010-07-08 | Mcneil-Ppc, Inc. | Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen |
ES2569925T3 (es) * | 2009-09-30 | 2016-05-13 | Acura Pharmaceuticals, Inc. | Métodos y composiciones de disuasión del abuso |
MX2012006240A (es) * | 2009-12-02 | 2012-10-03 | Aptalis Pharma Ltd | Microcapsulas de fexofenadina y composiciones que contienen las mismas. |
US20120276177A1 (en) | 2009-12-23 | 2012-11-01 | Colgate-Palmolive Company | Visually patterned and oriented compositions |
US9149959B2 (en) | 2010-10-22 | 2015-10-06 | Monosol Rx, Llc | Manufacturing of small film strips |
WO2012061360A2 (en) | 2010-11-01 | 2012-05-10 | Rib-X Pharmaceuticals, Inc. | Pharmaceutical compositions |
EP2717698A4 (en) * | 2011-06-09 | 2015-01-07 | Requis Pharmaceuticals Inc | ANTIHISTAMINES COMBINED WITH FOOD SUPPLEMENTS TO IMPROVE HEALTH |
AU2011379627B2 (en) | 2011-10-25 | 2015-09-10 | Expermed S.A. | Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof |
US20130177646A1 (en) * | 2012-01-05 | 2013-07-11 | Mcneil Ab | Solid Nicotine-Comprising Dosage Form with Reduced Organoleptic Disturbance |
RU2673818C2 (ru) | 2012-11-30 | 2018-11-30 | Экьюра Фармасьютикалз, Инк. | Саморегулируемое высвобождение фармацевтического ингредиента |
EP3003285B1 (en) * | 2013-06-03 | 2022-02-16 | McNeil AB | Solid pharmaceutical dosage form for release of at least two active pharmaceutical ingredients in the oral cavity |
TR201809617T4 (tr) * | 2013-12-04 | 2018-07-23 | Hovione Scientia Ltd | Tat maskeleme formülasyonları içeren kontrast ortamlar. |
EP3106152B1 (en) * | 2014-02-12 | 2021-02-17 | Sawai Pharmaceutical Co., Ltd. | Orally disintegrating tablet coated with film |
JP6510628B2 (ja) | 2014-03-26 | 2019-05-15 | サン・ファーマ・アドバンスト・リサーチ・カンパニー・リミテッド | 乱用防止即時放出性被覆リザーバ固体剤形 |
WO2017040607A1 (en) | 2015-08-31 | 2017-03-09 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
WO2017151571A1 (en) * | 2016-02-29 | 2017-09-08 | First Time Us Generics Llc | Abuse deterrent soft chewable drug formulations |
CA3022840A1 (en) | 2016-05-05 | 2017-11-09 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine compositions |
US11273131B2 (en) | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
MX2019000219A (es) * | 2016-07-05 | 2019-09-04 | Glaxosmithkline Consumer Healthcare Holdings Us Llc | Forma de dosificación oral que contiene un revestimiento exterior de liberación rápida. |
IL262768B (en) * | 2018-11-04 | 2020-08-31 | Ambrosia Supherb Ltd | Chewable tablet and method for its preparation |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3431138A (en) * | 1967-07-14 | 1969-03-04 | American Cyanamid Co | Method for coating pharmaceutical forms with methyl cellulose |
JPS5535031A (en) * | 1978-09-04 | 1980-03-11 | Shin Etsu Chem Co Ltd | Enteric coating composition |
US4309405A (en) * | 1979-08-09 | 1982-01-05 | American Home Products Corporation | Sustained release pharmaceutical compositions |
US4749575A (en) * | 1983-10-03 | 1988-06-07 | Bio-Dar Ltd. | Microencapsulated medicament in sweet matrix |
JPS61174940A (ja) * | 1985-01-29 | 1986-08-06 | Oogawara Kakoki Kk | ワックス類コーテイング単核状マイクロカプセルおよびその製造方法 |
US4868183A (en) * | 1986-07-21 | 1989-09-19 | Otsuka Pharmaceutical Factory, Inc. | N-pyrazinyl substituted P-aminophenols |
US4800087A (en) * | 1986-11-24 | 1989-01-24 | Mehta Atul M | Taste-masked pharmaceutical compositions |
DK130287D0 (da) * | 1987-03-13 | 1987-03-13 | Benzon As Alfred | Oralt praeparat |
US4916161A (en) * | 1988-10-25 | 1990-04-10 | Bristol-Myers Squibb | Taste-masking pharmaceutical agents |
US5372823A (en) * | 1989-03-16 | 1994-12-13 | Bristol-Myers Squibb Company | Direct compression cholestyramine tablet and solvent-free coating thereof |
WO1991014677A1 (fr) * | 1990-03-28 | 1991-10-03 | Otsuka Pharmaceutical Co., Ltd. | Derive de quinoline, medicament anti-ulcereux contenant ce derive et production de ce derive |
IT1246383B (it) * | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per il mascheramento del sapore di farmaci |
US5075114A (en) * | 1990-05-23 | 1991-12-24 | Mcneil-Ppc, Inc. | Taste masking and sustained release coatings for pharmaceuticals |
EP0458751A1 (en) * | 1990-05-25 | 1991-11-27 | Warner-Lambert Company | Delivery system for cyclic amino acids with improved taste, texture and compressibility |
GB9114184D0 (en) * | 1991-07-01 | 1991-08-21 | Unilever Plc | Detergent composition |
US5837277A (en) * | 1992-06-04 | 1998-11-17 | Smithkline Beecham Corporation | Palatable pharmaceutical compositions |
IT1264020B (it) * | 1993-01-28 | 1996-09-09 | Recordati Chem Pharm | Procedimento per la preparazione di microgranuli idonei alla sospensione in liquidi |
ATE195252T1 (de) * | 1993-04-23 | 2000-08-15 | Novartis Erfind Verwalt Gmbh | Wirkstoffabgabevorrichtung mit gesteuerter freigabe |
WO1995003052A1 (en) * | 1993-07-22 | 1995-02-02 | Warner-Lambert Company | Controlled release tacrine drug delivery systems and methods for preparing same |
ZA945944B (en) * | 1993-08-13 | 1996-02-08 | Eurand America Inc | Procedure for encapsulating nsaids |
JPH07223970A (ja) * | 1994-02-10 | 1995-08-22 | Tanabe Seiyaku Co Ltd | 消化管内適所放出製剤 |
US5958458A (en) * | 1994-06-15 | 1999-09-28 | Dumex-Alpharma A/S | Pharmaceutical multiple unit particulate formulation in the form of coated cores |
US5536507A (en) * | 1994-06-24 | 1996-07-16 | Bristol-Myers Squibb Company | Colonic drug delivery system |
US5681382A (en) * | 1995-08-22 | 1997-10-28 | Shin-Etsu Chemical Co., Ltd. | Rapidly soluble coating composition and method for preparing same |
US5789014A (en) * | 1995-12-25 | 1998-08-04 | Shin-Etsu Chemical Co., Ltd. | Method of manufacturing a solid preparation coated with non-solvent coating |
SE507471C2 (sv) * | 1996-08-09 | 1998-06-08 | Sunds Defibrator Ind Ab | Silpanel samt sätt för dess framställning |
IL129242A0 (en) * | 1996-10-01 | 2000-02-17 | Cima Labs Inc | Taste-masked microcapsule compositions and methods of manufacture |
US6046177A (en) * | 1997-05-05 | 2000-04-04 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
US6090401A (en) * | 1999-03-31 | 2000-07-18 | Mcneil-Ppc, Inc. | Stable foam composition |
US7223421B2 (en) * | 2000-06-30 | 2007-05-29 | Mcneil-Ppc, Inc. | Teste masked pharmaceutical particles |
-
2000
- 2000-12-21 US US09/745,243 patent/US20020119196A1/en not_active Abandoned
-
2001
- 2001-12-20 CA CA2365844A patent/CA2365844C/en not_active Expired - Fee Related
- 2001-12-21 CO CO01109552A patent/CO5390070A1/es not_active Application Discontinuation
- 2001-12-21 DE DE60135435T patent/DE60135435D1/de not_active Expired - Lifetime
- 2001-12-21 AR ARP010106010A patent/AR032037A1/es unknown
- 2001-12-21 JP JP2001390445A patent/JP2002272817A/ja active Pending
- 2001-12-21 ES ES01310751T patent/ES2311007T3/es not_active Expired - Lifetime
- 2001-12-21 CN CNB011454830A patent/CN100544705C/zh not_active Expired - Fee Related
- 2001-12-21 BR BR0106912-8A patent/BR0106912A/pt not_active Application Discontinuation
- 2001-12-21 EP EP01310751A patent/EP1219291B1/en not_active Expired - Lifetime
- 2001-12-21 ZA ZA200110547A patent/ZA200110547B/xx unknown
- 2001-12-21 NZ NZ516341A patent/NZ516341A/en unknown
- 2001-12-21 KR KR1020010082953A patent/KR20020050754A/ko not_active Application Discontinuation
- 2001-12-21 AT AT01310751T patent/ATE405250T1/de not_active IP Right Cessation
- 2001-12-21 AU AU97361/01A patent/AU783593B2/en not_active Ceased
-
2002
- 2002-01-07 MX MXPA02000277A patent/MXPA02000277A/es active IP Right Grant
- 2002-10-11 HK HK02107435.6A patent/HK1045817B/zh not_active IP Right Cessation
- 2002-11-25 HK HK02108500.4A patent/HK1046865A1/zh unknown
-
2012
- 2012-06-12 US US13/494,361 patent/US20120251623A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20120251623A1 (en) | 2012-10-04 |
EP1219291A1 (en) | 2002-07-03 |
CA2365844C (en) | 2010-07-06 |
DE60135435D1 (de) | 2008-10-02 |
HK1045817B (zh) | 2009-06-05 |
JP2002272817A (ja) | 2002-09-24 |
US20020119196A1 (en) | 2002-08-29 |
MXPA02000277A (es) | 2004-05-21 |
AR032037A1 (es) | 2003-10-22 |
CN1366878A (zh) | 2002-09-04 |
AU783593B2 (en) | 2005-11-10 |
EP1219291B1 (en) | 2008-08-20 |
NZ516341A (en) | 2003-08-29 |
BR0106912A (pt) | 2003-09-16 |
CA2365844A1 (en) | 2002-06-21 |
ATE405250T1 (de) | 2008-09-15 |
CN100544705C (zh) | 2009-09-30 |
AU9736101A (en) | 2002-06-27 |
ES2311007T3 (es) | 2009-02-01 |
HK1045817A1 (en) | 2002-12-13 |
KR20020050754A (ko) | 2002-06-27 |
CO5390070A1 (es) | 2004-04-30 |
HK1046865A1 (zh) | 2003-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200110547B (en) | Texture masked particles containing an active ingredient. | |
GB2359254B (en) | Formulation | |
ZA200205557B (en) | 4-Aminopicolinates and their use as herbicides. | |
ZA200204390B (en) | Caspase inhibitors and uses thereof. | |
AU2002212254A1 (en) | Microcapsule powder | |
AU1133002A (en) | Pesticide delivery system | |
ZA200200743B (en) | Preserved pharmaceutical formulations. | |
IL140974A0 (en) | Active prompts | |
AU2001234114A1 (en) | Drugs containing combined active ingredients | |
GB0000891D0 (en) | Formulation | |
MXPA03004980A (es) | Delta 1-pirrolinas usadas como pesticidas. | |
AU2001260122A1 (en) | Supragingival powder spraying | |
HK1057676A1 (en) | Egg-based powder and food containing the same | |
AU2001286242A1 (en) | Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient | |
ZA200107379B (en) | Pesticidal aerosol compositions and pesticidal methods. | |
PL366067A1 (en) | Oxayolidinone tablet formulation | |
AU2001240605A1 (en) | Endoparasiticidal agents | |
MXPA03001263A (es) | Formulacion fungicida. | |
ZA200102716B (en) | Solid pesticidal formulation. | |
HK1052168A1 (en) | N-deacetylthiocolchincine derivatives and pharmaceutical compositions containing them. | |
HK1043336A1 (en) | Finely-divided powder spray apparatus. | |
ZA200102153B (en) | Amidine compounds and their use as pesticides. | |
HK1043751A1 (en) | Finely-divided powder spray apparatus. | |
GB0031502D0 (en) | Aerosol formulation | |
EP1414417A4 (en) | PHARMACEUTICAL FORMULATION |